Can a simple blood thinner save teens from deadly clots?
NCT ID NCT06628778
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the blood thinner enoxaparin can prevent dangerous blood clots in teens who are critically ill in the intensive care unit. About 800 high-risk teens will receive either enoxaparin or a placebo. The goal is to see if the drug reduces clots without causing serious bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Enoxaparin (a blood thinner)
What this could lead to
If it works, this could provide a proven way to prevent dangerous blood clots in hospitalized teens, reducing complications and saving lives.
What could go wrong
This is a first-of-its-kind trial in children, so results are uncertain. Enoxaparin also raises bleeding risk, which must be carefully balanced against any benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM (VTE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins All Children"s Hospital
St. Petersburg, Florida, 33704, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact